Vandana Singh
·
September 16, 2025
Benzinga
Adial Pharmaceuticals received FDA backing for its Phase 3 AD04 trial, including endpoints and strategies for targeted populations in Alcohol Use Disorder treatment.
read more
September 5, 2025
August 12, 2025
Bloomberg
June 26, 2025
Barchart
June 21, 2025